Skip to main content
HairCited

维生素 D 用于 休止期脱发

F

基于32项研究(1项荟萃分析、1项RCT),共17,842名参与者。各研究结果不一。

<\/script>\n
`; }, get iframeSnippet() { const domain = 'haircited.com'; const params = 'ingredient\u003Dvitamin\u002Dd\u0026condition\u003Dtelogen\u002Deffluvium'; return ``; }, get activeSnippet() { return this.method === 'script' ? this.scriptSnippet : this.iframeSnippet; }, copySnippet() { navigator.clipboard.writeText(this.activeSnippet).then(() => { this.copied = true; setTimeout(() => { this.copied = false; }, 2000); }); } }" @keydown.escape.window="open = false" @click.outside="open = false">

Embed This Widget

Style



      
      
    

Widget powered by . Free, no account required.

F

结论

Despite frequent associations between low vitamin D and telogen effluvium, research does not clearly support vitamin D supplementation as an effective approach for this type of hair shedding.

  • Lower vitamin D levels are common in telogen effluvium patients but may not be the cause
  • No well-designed RCTs demonstrate that supplementation resolves telogen effluvium
  • Post-COVID hair loss studies show inconsistent findings regarding vitamin D
  • Correcting a deficiency is reasonable, but vitamin D alone is unlikely to resolve hair shedding

Key Study Findings

retrospective observational n=113
Telogen Effluvium Following Coronavirus Disease-2019 Infection: A Retrospective Study of 113 Cases.
Dose: None vs: Placebo 效果: None None
narrative review
Addressing the Root Causes of Female Hair Loss and Non-Pharmaceutical Interventions.
Dose: None vs: Placebo 效果: None None
Meta-analysis
Vitamin D deficiency in non-scarring and scarring alopecias: a systematic review and meta-analysis.
Dose: None vs: Placebo 效果: OR=2.84 (AA vs controls), OR=5.24 (FPHL vs controls) p<0.01
meta_analysis n=10670
Serum 25 hydroxyvitamin D in non-scarring alopecia: A systematic review and meta-analysis.
Dose: not applicable (observational meta-analysis) vs: Placebo 效果: WMD -7.29 ng/mL (95% CI -9.21, -5.38); OR for vitamin D deficiency 3.11 (95% CI 2.29, 4.22) not explicitly stated; CI does

Key Statistics

34

研究数量

17842

受试者

Mixed

F

等级

Referenced Papers

Archives of dermatological … 2023 3 次引用
Journal of dermatological … 2021 51 次引用
Journal of cosmetic … 2021 44 次引用
International journal of … 2020 18 次引用
International journal of … 2017 61 次引用
Skin pharmacology and … 2013 127 次引用

Dosage & Usage

mg = milligrams · mcg = micrograms (1,000× smaller) · IU = International Units

常用剂量

general:
600-800 IU/day
deficiency:
1,000-5,000 IU/day

上限: 4,000 IU/day

研究中使用的剂量

剂量 持续时间 效果 N
None -- Neutral 113
None -- Positive --
None -- Mixed --
None -- Negative --
not applicable -- Mixed 180
not applicable (observational meta-analysis) -- Negative 10670
None -- Mixed 100
None -- Neutral 120

最佳服用时间: With a fat-containing meal for optimal absorption

Safety & Side Effects

已报告的副作用

  • Hypercalcemia at very high doses (nausea, vomiting, weakness)
  • Kidney stones with excessive long-term use
  • Constipation
  • Metallic taste

已知相互作用

  • Thiazide diuretics (may increase risk of hypercalcemia)
  • Corticosteroids (reduce vitamin D absorption and metabolism)
  • Orlistat and cholestyramine (reduce fat-soluble vitamin absorption)

可耐受最高摄入量: 4,000 IU/day

在开始服用任何补充剂之前,请务必咨询您的医疗保健提供者。

Frequently Asked Questions

Does 维生素 D help with 休止期脱发?
Based on 34 studies with 17,842 participants, there is insufficient evidence at this time that 维生素 D may support 休止期脱发 management. Our evidence grade is F (Evidence Against).
How much 维生素 D should I take for 休止期脱发?
Studies have used various dosages. A commonly studied range is 600-800 IU/day. Always consult your healthcare provider before starting any supplement regimen.
Are there side effects of 维生素 D?
Reported side effects may include Hypercalcemia at very high doses (nausea, vomiting, weakness), Kidney stones with excessive long-term use, Constipation, Metallic taste. Most side effects are mild and dose-dependent. Consult your doctor if you experience any adverse reactions.
How strong is the evidence for 维生素 D and 休止期脱发?
We rate the evidence as Grade F (Evidence Against). This rating is based on 34 peer-reviewed studies with 17,842 total participants. The overall direction of effect is mixed.

Related Evidence

FDA 免责声明: 这些声明未经美国食品药品监督管理局(FDA)评估。本网站上的产品和信息无意用于诊断、治疗、治愈或预防任何疾病。所展示的证据等级基于我们对已发表的同行评审研究的分析,不构成医疗建议。在开始任何补充剂方案之前,请务必咨询您的医疗保健提供者。